Bharat Parenterals enterprise value

·Pharma & HealthChart ›
MultiplesEnterprise valuePer share
Share price at each year-end
Tap a line for its trendCurrentlast closeFY23Mar 2023FY22Mar 2022
1,105——
6.46.414.8
6.96.99.7
1,105——
0.50.5−5.1
₹1,913.83——
198198176
3.5%3.5%5.5%
0.01×——
5.07×——
51.73×——
71.23×——
−95.61×——
Reference items — trailing FY values
218218212
21.421.428.1
15.515.521.5
−11.6−11.6—
−11.6−11.6—
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

BPLPHARMA₹1,912.90

Bharat Parenterals Limited

· Pharma & Health
₹ CrorePeersJENBURPHKPLMAKERSLNOVARTINDPARNAXLABSGRLSHUKRAPHARSUNLOCMcap ₹1,105 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY22
31/03/2022
FY23
31/03/2023
Current
last close
Market Capitalization——1,104.7
- Cash, Equiv & ST Investments14.86.46.4
+ Total Debt9.76.96.9
Enterprise Value——1,105.3
Net Debt (memo)-5.10.50.5
EV per Share——1,913.83
Total Capital175.9198.0198.0
Total Debt/Total Capital5.543.483.48
Total Debt/EV——0.01
EV/Sales——5.07
EV/EBITDA——51.73
EV/EBIT——71.23
EV/Operating Cash Flow——-95.61
Reference Items — Trailing FY Values
Sales212.0218.0218.0
EBITDA28.121.421.4
EBIT21.515.515.5
Operating Cash Flow—-11.6-11.6
Free Cash Flow—-11.6-11.6
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY23 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.